Profiled Companies

logoAethlon Medical, Inc. (OTCQB:AEMD) mission is to create innovative devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. The Aethlon ADAPT system is an expansive technology platform that converges affinity drug agents and plasma membrane technology to create therapeutic filtration devices that selectively target the removal of harmful particles from the entire circulatory system. Our lead therapeutic candidate is the Aethlon Hemopurifier, a device with broad-spectrum capabilities against viral pathogens and immunosuppressive cancer exosomes. In human studies, Hemopurifier therapy has provided significant viral load reductions in HIV and hepatitis C virus infected individuals without the administration of antiviral drugs. We are now focused on advancing our Hemopurifier as an adjunct strategy to improve the benefit of established infectious disease and cancer treatment regimens. Based on studies conducted by government and non-government research organizations, the Hemopurifier is also a leading broad-spectrum treatment candidate to address bioterror and pandemic threats. Read More

 


BrainStorm Cell TherapeuticsBrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI)
 is a clinical-stage biotechnological company developing innovative, adult stem cell therapeutic products, derived from autologous bone marrow cells, for the treatment of highly debilitating neurodegenerative disorders. The company’s current primary targets are Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig’s disease) and Parkinson?s disease (PD). These devastating diseases have no treatment options and as such represent highly unmet medical needs. Upon completion of BrainStorm?s clinical trials program and regulatory approvals, this novel therapy will provide compelling medical and economic benefits for patients, medical practitioners, and insurance/healthcare providers. By redirecting the inherent regenerative capacities of adult stem cells towards treating the basic disease pathologies, BrainStorm will enable healthcare institutions and society at large to realize massive savings in treatment and care costs. The Company holds rights to develop and commercialize the technology through an exclusive, worldwide licensing agreement with Ramot, the technology transfer company of the Tel-Aviv University.Read More

Ecoark Holdings, Inc. (OTCQX: EARK) is a growth-oriented company based in the retail and logistics hub of Northwest Arkansas. Ecoark’s current portfolio of subsidiaries monetize the reduction of waste in Operations, Logistics, and Supply Chains across the evolving global economy. Ecoark’s vision is to deploy a company-first philosophy using radical transparency to optimize capital deployment via aggressive deal flow sourcing and vetting, and achieve financial objectives by hiring and developing strong, properly incentivized managers.Ecoark addresses these vital economic factors through three active subsidiaries, Zest Labs, Pioneer Products, and Magnolia Solar.Read More

 

RJD Green (OTC PINK: RJDG) operates as a holding company with a focus of acquiring and managing assets and companies. RJD Green operates in three divisions: RJD Green Healthcare Services Division, which holds interest in IoSoft Inc, a company that provides discrete payment technologies, services and software that can be integrated into targeted offerings for healthcare provider networks, hospitals, healthcare payers and individual providers: Earthlinc Environmental Services Division, which provides green environmental services and technologies; Silex Holdings Division, which is engaged in specialty construction and industrial manufacturing and fills a market niche between the Home Depots and local contractors. Silex offers installed granite/other counter tops, cabinets and related products to the residential builder, commercial contractor, remodel contractor and retail customer. Read More

 

Groupe Athena Inc.(Pink sheets GATA.PK) was incorporated in June 2008 and began operations on July 1 of that year. The company is a research and testing organization and helps various pharmaceutical and medical products and devices companies in India and Southeast Asia to get regulatory approvals and facilitate exports of their products to the United States. The Company accomplishes this by assisting clients from concept through development, providing consultation on regulatory requirements, filings and processes. The company has a research and marketing facility in India that currently employs 22 consultants and marketing personnel and is working towards aggressively expanding its presence in the Indian pharmaceutical industry. Read More

 

iscoInternational Stem Cell Corporation (OTCQB: ISCO) is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. ISCO’s core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenetic, homozygous stem cell line that can be a source of therapeutic cells for hundreds of millions of individuals of differing genders, ages and racial backgrounds, with minimal immune rejection after transplantation. hpSCs offer the potential to create the first true stem cell bank, UniStemCell?. ISCO also produces and markets specialized cells and growth media for therapeutic research through its subsidiary Lifeline Cell Technology (www.lifelinecelltech.com), and stem cell-based skin care products through its subsidiary Lifeline Skin Care Read More

 

Medical Marijuana, Inc. (OTC PINK: MJNA) is the first publicly held company vested in the medical marijuana and industrial hemp markets. The company is comprised of a diversified portfolio of products, services, technology and businesses solely focused on the cannabis and hemp industries. These products range from patented and proprietary based cannabinoid products, to seed and stalk or isolated high value extracts specifically manufactured and formulated for the pharmaceutical, nutraceutical and cosmeceutical industries. The Company’s services are extensive and varied, ranging from medical clinic management to the capitalization and development of existing industry business and product leaders. Services include development of cannabinoid based health and wellness products, and the development of medical grade compounds. MJNA provides over 85 proprietary and patented cannabinoid delivery methods that are more socially and medically acceptable than typical industry methods. Finally, MJNA services include the licensing of its proprietary testing, genetics, labeling, and packaging, tracking, production and standardization methods for the medicinal herb industry. Medical Marijuana Inc.’s patented and proprietary technologies include the only pharmaceutical grade vertical Bio-Technology Company specializing in the standardization, production and extraction of phyto-cannabinoids. MJNA’s PhytoSPHERE Systems and their advanced plant growth technologies save significantly on resources necessary for production of medical grade cannabis. In addition to providing a medical grade end product, extracts and compounds, PhytoSPHERE Systems also includes pre-and-post production tracking, germplasm references, packaging and processing to ensure consistency and genetic purity. Medical Marijuana Inc. (OTC: MJNA) Portfolio. Read More

 

AppSwarm, Inc. (SWRM) Established in 2011, AppSwarm™ is an application incubation firm dedicated to acquiring applications for all forms of devices. They have resources most small firms or young entrepreneurs and application developers usually do not have to market applications the most effective way possible. With agreements in place with major application stores they can fast track projects. They offer complete, end-to-end services for mobile application development across all major platforms including Apple iPhone, RIM’s BlackBerry, Google’s Android, as well as Microsoft’s Windows Mobile. With their extensive experience in the mobile space, they can not only give applications a technical hand, but can be a strategic partner in leveraging this dynamic mobile world towards increased business efficiency and effectiveness. Read More

 

logo-tranparent

Galenfeha, Inc. (OTC: GLFH) is a design, engineering, and manufacturing firm with a focus on stored energy solutions with low environmental impact.  Galenfeha designs, manufactures and markets a complete line of patent pending, microprocessor controlled, LiFePO4 chemistry battery systems for Oil and Gas measurement and automation as well as a full line of proprietary high precision chemical injection systems.  The company also provides stored energy solutions for U.S. military applications.Read More

 

logoPositiveID Corporation (OTCQB:PSIDD) develops molecular diagnostic systems for bio-threat detection and rapid medical testing. The Company’s proprietary airborne pathogen detection system called M-BAND (Microfluidic Bio-agent Autonomous Networked Detector), continuously and autonomously analyzes air samples for the detection of biological airborne threats in the form of bacteria, viruses, and toxins. PositiveID’s Firefly Dx is a point-of-need, handheld system designed to deliver molecular diagnostic results using real-time polymerase chain reaction (PCR) chemistry. Firefly Dx is being developed to meet the growing need in healthcare and molecular diagnostics markets by enabling hospitals, physicians and other providers to save lives and fight disease. PositiveID also markets Caregiver(R), the first FDA-cleared non-contact thermometer that uses infrared technology. Read More

 

PrintProtoKinetix, Incorporated (OTCQB:PKTX) is a research and development stage biotechnology company focused on scientific medical research of AFGPs (Anti-Freeze Glycoproteins) or anti-aging glycoproteins, and has developed and patented a family of hyper-stable, potent glycopeptides trademarked as AAGPs that enhance the therapeutic results and can reduce the cost of stem cell medicine. Due to the anti-inflammatory effect of AAGPTM molecules, the Company is currently in the process of directing major efforts to target the direct treatment of diseases that have a major inflammatory component. Read More

 

Home_Tech_Precision_LogoTechPrecision Corporation (OTCQB: TPCS)Founded in February 2006, TechPrecision Corporation is a holding company that’s driven to provide businesses with the most well-engineered, cost-effective turnkey solutions to their large-scale component and equipment manufacturing challenges. By assembling experienced metal fabrication companies that specialize in unique, demanding global industries, TechPrecision provides clients with access to knowledge, resources, and technologies that span some of the most demanding manufacturing sectors. Read More

2017 OTC PR Group, All Rights Reserved
Menu Title